ES2550105B2 - Lentes de contacto para conjuntivitis alérgica - Google Patents

Lentes de contacto para conjuntivitis alérgica Download PDF

Info

Publication number
ES2550105B2
ES2550105B2 ES201530906A ES201530906A ES2550105B2 ES 2550105 B2 ES2550105 B2 ES 2550105B2 ES 201530906 A ES201530906 A ES 201530906A ES 201530906 A ES201530906 A ES 201530906A ES 2550105 B2 ES2550105 B2 ES 2550105B2
Authority
ES
Spain
Prior art keywords
allergic conjunctivitis
contact lenses
hydrogels
olopatadine
hema
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES201530906A
Other languages
English (en)
Other versions
ES2550105A1 (es
Inventor
Carmen ÁLVAREZ LORENZO
Clara GONZÁLEZ CHOMON
Ángel CONCHEIRO NINE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade de Santiago de Compostela
Original Assignee
Universidade de Santiago de Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade de Santiago de Compostela filed Critical Universidade de Santiago de Compostela
Priority to ES201530906A priority Critical patent/ES2550105B2/es
Publication of ES2550105A1 publication Critical patent/ES2550105A1/es
Priority to PCT/ES2016/070466 priority patent/WO2016207460A1/es
Application granted granted Critical
Publication of ES2550105B2 publication Critical patent/ES2550105B2/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/12—Esters of monohydric alcohols or phenols
    • C08F220/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
    • C08F220/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
    • C08F220/1807—C7-(meth)acrylate, e.g. heptyl (meth)acrylate or benzyl (meth)acrylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/04—Acids; Metal salts or ammonium salts thereof
    • C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
    • C08L33/08—Homopolymers or copolymers of acrylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
    • C08L33/10—Homopolymers or copolymers of methacrylic acid esters
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Lentes de contacto para conjuntivitis alérgica. La presente invención se refiere a hidrogeles, sistemas de liberación y dispositivos ópticos adecuados para el tratamiento o prevención de la conjuntivitis alérgica, en particular, la conjuntivitis alérgica estacional. Los hidrogeles de la invención son útiles en lentes de contacto blandas, y para cargar principios activos antihistamínicos como olopatadina, ketotifeno o azelastina en una cantidad suficiente para provocar una respuesta de eficacia adecuada.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
durante 24 horas y finalmente en agua otra semana. Finalmente, los discos se secaron a 70 ºC durante 12 h.
Tabla 1. Composición de los hidrogeles imprinted (hidrogeles con números pares) y no imprinted (hidrogeles con números impares). A todas las mezclas de monómeros se les incorporó 1 mL de DMSO y 0.00821 g de AIBN.
Hidrogel
HEMA (mL) Fármaco (g) AAc (µL) BzMA (µL) AAm (g) AMPSA (g) EGDMA (µL)
1
4 0 0 0 0 0 188.6
3
4 0 68.6 0 0.072 0 188.6
17
4 0 68.6 338.9 0 0 188.6
23
4 0 137.2 0 0.144 0 188.6
25
4 0 68.6 338.9 0 0.207 188.6
29
4 0 68.6 338.9 0.072 0.207 377.2
2
4 0.1869 0 0 0 0 188.6
4
4
0.1869 68.6 0 0.072 0 188.6
18
4 0.1869 68.6 338.9 0 0 188.6
24
4 0.1869 137.2 0 0.144 0 188.6
26A
4 0.1869 68.6 338.9 0 0.207 188.6
26B
4 0.0935 68.6 338.9 0 0.207 188.6
30A
4 0.1869 68.6 338.9 0.072 0.207 377.2
30B
4 0.0935 68.6 338.9 0.072 0.207 377.2
10 2. Caracterización de los hidrogeles A continuación se recogen los métodos empleados en la caracterización de los hidrogeles preparados, y los resultados.
2.1 Calorimetría diferencial de barrido (DSC)
15 Se llevaron a cabo análisis de DSC en un DSC Q-100 (TA Instruments, USA) equipado con un sistema de refrigeración. Fragmentos de discos secos (4-6 mg) se colocaron en cápsulas de aluminio y se sometieron a calefacción hasta 150ºC, se mantuvieron 5
imagen20
imagen21
imagen22
20 días. Los discos preparados con HEMA sin monómeros funcionales (hidrogeles 1 y 2) fueron capaces de incorporar 30 mg/g en los primeros 5 días y hasta 38 mg/g cuando alcanzaron el equilibrio. La cantidad de olopatadina que estos discos de HEMA fueron capaces de alojar en fase acuosa fue de 0.1 mg/g lo que significa que el coeficiente de 5 reparto de olopatadina entre la red polimérica y el agua es de 188 (tabla 3). La cantidad de olopatadina cargada por el hidrogel 1 está en concordancia con los datos publicados para Acuvue (J&J) sumergidas en Patanol (hidrocloruro de olopatadina disolución oftálmica al 0.1%) (N.L. Dassanayake, T. C. Carey, G. R. Owen. A Laboratory Model to Determine the Uptake and Release of Olopatadine by Soft Contact Lenses. Acta
10 Ophthalmol. Scand. 2000: 78: 16–17). Los hidrogeles que combinan AAc, BzMA y AMPSA (hidrogel 25) cargan olopatadina más rápido y en una cantidad dos veces mayor que los hidrogeles preparados solamente con HEMA (figura 3). Tabla 3. Datos de carga de olopatadina y coeficiente de reparto de olopatadina entre la
15 red polimérica y el agua.
Hidrogel
Olopatadina incorporada (mg/g) KN/W
1
38.51 188
3
39.34 192
17
52.05 255
23
52.27 255
25
79.42 389
29
87.22 427
2
37.25 182
4
46.39 227
18
41.87 205
24
50.64 248
26A
59.51 291
26B
69.15 339
30A
56.70 277
30B
85.64 420
imagen23
imagen24

Claims (1)

  1. imagen1
    imagen2
    imagen3
ES201530906A 2015-06-25 2015-06-25 Lentes de contacto para conjuntivitis alérgica Active ES2550105B2 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201530906A ES2550105B2 (es) 2015-06-25 2015-06-25 Lentes de contacto para conjuntivitis alérgica
PCT/ES2016/070466 WO2016207460A1 (es) 2015-06-25 2016-06-20 Lentes de contacto para conjuntivitis alérgica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201530906A ES2550105B2 (es) 2015-06-25 2015-06-25 Lentes de contacto para conjuntivitis alérgica

Publications (2)

Publication Number Publication Date
ES2550105A1 ES2550105A1 (es) 2015-11-04
ES2550105B2 true ES2550105B2 (es) 2016-10-07

Family

ID=54353325

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201530906A Active ES2550105B2 (es) 2015-06-25 2015-06-25 Lentes de contacto para conjuntivitis alérgica

Country Status (2)

Country Link
ES (1) ES2550105B2 (es)
WO (1) WO2016207460A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106084116B (zh) * 2016-06-17 2019-02-05 宁波国际材料基因工程研究院有限公司 水凝胶及其制备方法，水凝胶的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123407A (en) * 1976-11-26 1978-10-31 American Optical Corporation Hydrophilic contact lens
MX2007009417A (es) * 2005-02-04 2007-08-17 Univ Auburn Sistema de suministro de farmaco de contacto.
US9389336B2 (en) * 2013-08-02 2016-07-12 Bausch & Lomb Incorporated Hydrogel monomer mix containing added water

Also Published As

Publication number Publication date
ES2550105A1 (es) 2015-11-04
WO2016207460A1 (es) 2016-12-29

Similar Documents

Publication Publication Date Title
Elbaum-Garfinkle et al. The disordered P granule protein LAF-1 drives phase separation into droplets with tunable viscosity and dynamics
Liu et al. Trehalose induces autophagy against inflammation by activating TFEB signaling pathway in human corneal epithelial cells exposed to hyperosmotic stress
Rog et al. The synaptonemal complex has liquid crystalline properties and spatially regulates meiotic recombination factors
Knobloch et al. Dendritic spine loss and synaptic alterations in Alzheimer’s disease
Benson et al. Mathematical optimization of procedures for cryoprotectant equilibration using a toxicity cost function
ES2481641T3 (es) Uso de receptor inmunosupresor
Liu et al. Autophagy activation aggravates neuronal injury in the hippocampus of vascular dementia rats
ES2550105B2 (es) Lentes de contacto para conjuntivitis alérgica
ES2688030T3 (es) Péptidos permeables celulares inhibidores de la ruta de transducción de la señal JNK para su uso en el tratamiento de enfermedades oculares inflamatorias
Han et al. A mouse model of corneal endothelial decompensation using cryoinjury
Caldeira-Dias et al. Resveratrol improves endothelial cell markers impaired by plasma incubation from women who subsequently develop preeclampsia
Muraleva et al. The mitochondria-targeted antioxidant SkQ1 restores α B-crystallin expression and protects against AMD-like retinopathy in OXYS rats
Lanzini et al. In vivo and impression cytology study on the effect of compatible solutes eye drops on the ocular surface epithelial cell quality in dry eye patients
Turedi et al. The diagnostic value of plasma SCUBE1, a novel biomarker of platelet activation, in testicular torsion: A randomized, controlled, experimental study
KR20160004288A (ko) 약학적 조성물 및 이의 용도
Nikoletopoulou et al. Necrotic cell death in Caenorhabditis elegans
Buzgariu et al. Chapter Twenty‐Six Methods to Investigate Autophagy During Starvation and Regeneration in Hydra
Salmon et al. CXL at the slit lamp: no clinically relevant changes in corneal riboflavin distribution during upright UV irradiation
Ktistakis Monitoring the localization of MAP1LC3B by indirect immunofluorescence
Marrari et al. Analysis of microtubule movement on isolated Xenopus egg cortices provides evidence that the cortical rotation involves dynein as well as Kinesin Related Proteins and is regulated by local microtubule polymerisation
Morris Cytotoxic swelling of sick excitable cells–impaired ion homeostasis and membrane tension homeostasis in muscle and neuron
Lee et al. Spatiotemporal regulation of signaling in and out of dendritic spines: CaMKII and Ras
RU2016111957A (ru) Офтальмическая композиция для цвиттерионных мягких контактных линз
Sheng et al. Cortical localization of α-and γ-tubulin and the assembly of cortical microtubule cytoskeleton in Hypotrichous ciliate Euplotes eurystomus
Hipolito et al. Enhanced and selective translation expands the lysosome size and promotes antigen presentation during phagocyte activation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2550105

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20161007